Bleomycin Electrosclerotherapy Treatment in the Management of Vascular Malformations.

Background: Intralesional injection of a sclerosing agent is a standard treatment for vascular malformations, but many repeat treatments are often required to achieve a response. The temporary application of an electrical field to the treated area increases cellular membrane permeability and therefore augments drug delivery.

Objective: To report a case series of patients with vascular malformations who received bleomycin electrosclerotherapy (EST).